VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Umbilical Cord Blood administration
Preclinical
Biologic
M
MinYoung Kim, M.D.
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Developmental Delay
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Developmental Delay
Preclinical
Completed
Clinical
Trials by Indication
[1]
Developmental Delay
1 trial
Umbilical Cord Blood Therapy for Children With Global Developmental Delay
Completed
·
M
MinYoung Kim, M.D.
·
N/A
·
NCT01601158
·
10 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Umbilical Cord Blood administration. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Umbilical Cord Blood administration compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Umbilical Cord Blood administration. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
MinYoung Kim, M.D. company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Biologic
[2]
Highest Phase
Preclinical
[1]
Company
M
MinYoung Kim, M.D.
Related News